Congratulations for bringing Children Covid vaccine India

Congratulations for bringing Children Covid vaccine India

Children Covid vaccine India, InshaAllah; Covaxin will become the world’s first Covid-19 vaccine for use in children as young as 2 years. The expert panel advising India’s drug regulator  recommended granting emergency use authorisation to the vaccine for children in the 2-18 years age group. Institute has been asked to submit data on any adverse event following vaccination; every 15 days for the next two months. Government asked the institute to update the package inserts, fact sheet, and summary of product characteristics for its vaccine pack. Bharat Biotech said it was awaiting further regulatory approval from the Central Drugs Standard Control Organisation (CDSCO) before the company could launch the product for children. Alhamdulillah, The Subject Expert Committee (SEC) has submitted its recommendation to the drug regulator. Meanwhile a formal approval from the Drugs Controller General of India (DCGI)  expected after he examines the data and the recommendation.

Alhamdulillah CDSCO and SEC, have provided their positive recommendations for covaxin.

Bharat Biotech has submitted data from clinical trials in the 2-18 years’ age group for Covaxin (BBV152) to the CDSCO. The data has been thoroughly reviewed by the CDSCO and SEC, and they have provided their positive recommendations. JazakAllah, The firm had submitted data from its paediatric trials to the regulator last week. The gap between the two doses of Covaxin will be 28 days, as in the case of adults. The company confirmed that the vaccine for children was the same drug substance as Covaxin.

Moreover This represents one of the first approvals worldwide for Covid-19 vaccines for the 2-18 age groups. Bharat Biotech has struggled to keep pace with demand for its Covid-19 shots. The company has indicated it would make 55 million; doses in October and is aiming to touch 80 million doses a month by December. As of now, the other vaccines approved for children so far are for use in three years and above. Institute of India is conducting trials on children aged 7 years and above for US major Covid-19 vaccine (Covovax) here. Once again congratulation toh Bharat biotech and covaxin for their endeavours

You may also like...

1 Comment

  1. […] the countryside. In the last two decades it has emerged as one of loudest advocates for women and children rights in the countryside. Women in rural communities’ experience higher rates of […]

Leave a Reply

Your email address will not be published.